Search

Your search keyword '"Owen, Kr"' showing total 153 results

Search Constraints

Start Over You searched for: Author "Owen, Kr" Remove constraint Author: "Owen, Kr"
153 results on '"Owen, Kr"'

Search Results

3. Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (vol 50, pg 26, 2018)

4. Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (vol 50, pg 765, 2017)

5. Erratum: Sequence data and association statistics from 12,940 type 2 diabetes cases and controls.

6. Data Descriptor: Sequence data and association statistics from 12,940 type 2 diabetes cases and controls

14. Reclassification of diabetes etiology in a family with multiple diabetes phenotypes

18. Common variation in the LMNA gene (encoding lamin A/C) and type 2 diabetes: association analyses in 9,518 subjects

20. Reclassification of diabetes aetiology in a family with multiple diabetes phenotypes

22. The Lin28/let-7 axis regulates glucose metabolism

23. Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis

24. Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes

25. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility

27. Erratum: Corrigendum: Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis

29. Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young.

30. Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations.

31. Evaluation of serum 1,5 anhydroglucitol levels as a clinical test to differentiate subtypes of diabetes.

32. Common variation in the LMNA gene (encoding lamin A/C) and type 2 diabetes: association analyses in 9,518 subjects.

33. Assessment of the Role of Common Genetic Variation in the Transient Neonatal Diabetes Mellitus (TNDM) Region in Type 2 Diabetes: A Comparative Genomic and Tagging Single Nucleotide Polymorphism Approach.

34. Examining the relationships between the Pro12Ala variant in PPARG and Type 2 diabetes-related traits in UK samples.

35. A large-scale association analysis of common variation of the HNF1alpha gene with type 2 diabetes in the U.K. Caucasian population.

37. The clinical application of non-genetic biomarkers for differential diagnosis of monogenic diabetes.

38. Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes

39. A Genome-Wide Association Search for Type 2 Diabetes Genes in African Americans

40. Novel Loci for Adiponectin Levels and Their Influence on Type 2 Diabetes and Metabolic Traits: A Multi-Ethnic Meta-Analysis of 45,891 Individuals

41. Transdermal Blood Sampling for C-Peptide Is a Minimally Invasive, Reliable Alternative to Venous Sampling in Children and Adults With Type 1 Diabetes.

42. Low-Field Magnetic Resonance Imaging Findings of the Fetlock Region of Nonracehorses.

43. The use of precision diagnostics for monogenic diabetes: a systematic review and expert opinion.

44. Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine.

45. First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes.

46. A Systematic Review of the use of Precision Diagnostics in Monogenic Diabetes.

47. Development of an exoglycosidase plate-based assay for detecting α1-3,4 fucosylation biomarker in individuals with HNF1A-MODY.

48. Fucosylated AGP glycopeptides as biomarkers of HNF1A-Maturity onset diabetes of the young.

49. Intratendinous Fibroma of the Superficial Digital Flexor Tendon within the Carpal Sheath of a Horse.

50. Interlaboratory evaluation of plasma N-glycan antennary fucosylation as a clinical biomarker for HNF1A-MODY using liquid chromatography methods.

Catalog

Books, media, physical & digital resources